z-logo
open-access-imgOpen Access
Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders
Author(s) -
Kevin M. Nash,
Zahoor Ahmad
Publication year - 2015
Publication title -
integrative medicine insights
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.933
H-Index - 12
ISSN - 1177-3936
DOI - 10.4137/imi.s25054
Subject(s) - ginkgo biloba , ginkgolides , medicine , pharmacology , anxiolytic , migraine , ischemic stroke , stroke (engine) , dementia , ischemia , anesthesia , psychiatry , anxiety , mechanical engineering , disease , engineering
Ginkgo biloba extract is an alternative medicine available as a standardized formulation, EGb 761(®), which consists of ginkgolides, bilobalide, and flavonoids. The individual constituents have varying therapeutic mechanisms that contribute to the pharmacological activity of the extract as a whole. Recent studies show anxiolytic properties of ginkgolide A, migraine with aura treatment by ginkgolide B, a reduction in ischemia-induced glutamate excitotoxicity by bilobalide, and an alternative antihypertensive property of quercetin, among others. These findings have been observed in EGb 761 as well and have led to clinical investigation into its use as a therapeutic for conditions such as cognition, dementia, cardiovascular, and cerebrovascular diseases. This review explores the therapeutic mechanisms of the individual EGb 761 constituents to explain the pharmacology as a whole and its clinical application to cardiovascular and neurological disorders, in particular ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom